[1] 何华伟, 黄爱春, 陆普选, 等. WHO 2025年全球结核病报告:全球与中国关键数据分析[J/CD]. 新发传染病电子杂志, 2025, 10(6):1-9. [2] FERNANDES F, MELO DTP, RAMIRES FJA, et al.Importance of Clinical and Laboratory Findings in the Diagnosisand Surgical Prognosis of Patients with Constrictive Pericarditis[J]. Arq Bras Cardiol, 2017, 109(5):457-465. [3] 唐神结,高文. 临床结核病学[M].北京:人民卫生出版, 2019: 597. [4] DYBOWSKA M, BASISKA K, GTAREK J, et al.Personal Experience and Recent Recommendations in Tuberculous Pericarditis[J]. Diagnostics (Basel), 2022, 12(3):619. [5] TERRENCE D, WELCH, JAE K.et al.Constrictive Pericarditis[J]. Cardiol Clin,2017,35(4):539-549. [6] 魏宇森, 廖玉华, 王国荣, 等. 快速进展至心包缩窄的结核性心包炎临床分析[J]. 临床内科杂志, 2006, 23(10):686-688. [7] JOTAM G, PASIPANODYA, MWENYA MUBANGA, et al.Tuberculous Pericarditis is Multibacillary and BacterialBurden Drives High Mortality[J]. EBio Medicine, 2015, 2(11):1634-1639. [8] SHAMMAS NW, PADARIA RF, COYNE EP.Pericarditis myocarditis and other cardiomyopathies[J]. Prim Care, 2013, 40(1):213-236. [9] SCHULZ-MENGER J, COLLINI V, GROSCHEL J, et al.2025 ESC Guidelines for the management of myocarditis and pericarditis[J]. Eur Heart J,2025,46(40):3952-4041. [10] YACOUB M, QUINTANILLA RODRIGUEZ BS, MAHAJAN K.Constrictive-Effusive Pericarditis[M/OL]. Treasure Island (FL):StatPearls Publishing, 2023. [11] 刘延玲, 熊鉴然. 临床超声心动图学[M].4版. 北京:科学出版社, 2022:5. [12] ISHIGUZO G, DUBRUN E, HOLLETT P, et al.Diagnosis and treatment of tuberculous pericarditis: What are the new advances?[J]. Curr Cardiol Rep, 2020, 22(1):2. [13] 李彪, 陈范才, 谢和宾, 等. 结核性与非特异性缩窄性心包炎53例临床特征分析[J]. 中国感染与化疗杂志, 2020, 20(4):384-387. [14] IMAZIO M,BRUCATO A,MAESTRONI S,et al.Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis:implications for the diagnosis,therapy,and prognosis of pericarditis[J]. Circulation, 2011, 123(10):1092-1097. [15] PISACRETA AM, MASECOLO R, NIVUORI M, et al.Acute pericarditis with pleuropulmonary involvement, fever and elevated C-reactive protein:a systemicautoinflammatory disease? A cohort study[J]. Eur J Intern Med, 2023, 113(1):45-48. [16] YANG J, XIANG W, HE R, et al.Tuberculous constrictive pericarditis: "armored heart"[J]. QJM, 2024, 117(9):679-680. [17] YADAV NK, SIDDIQUE MS.Constrictive Pericarditis[M/OL]. Treasure Island (FL): StatPearls Publishing, 2023. [18] GILIOMEE LJ, DOUBEL AF, ROBBERTSE PS, et al.Cardiovascular MRI's New Role in Predicting Tuberculous Pericarditis and Edema as a Marker for Constrictive Pericarditis[J]. Front Cardiovasc Med, 2024, 11:1329767. [19] MCDONAGH TA, METRA M, ADAMO M, et al.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42(36):3599-3726. [20] JACK HARTNETT, NIALL CONNOLLY, ROSS MURPHY, et al.A cursed duet-a case of tuberculous effusive-constrictive pericarditis[J]. Irish J Med Sci, 2025, 194(3):1561-1566. [21] IKRAM UHAQ, DANIEL RDAVIES, REBECCA YAO, et al.Effusive-Constrictive Tuberculosis Pericarditis with Biventricular Systolic Dysfunction[J]. Cardiovasc Imaging Case Rep, 2022, 6(5):212-217. |